These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 21810045)

  • 1. Better late than never: antivirals for dengue.
    Perry ST; Buck MD; Shresta S
    Expert Rev Anti Infect Ther; 2011 Jul; 9(7):755-7. PubMed ID: 21810045
    [No Abstract]   [Full Text] [Related]  

  • 2. Biological characteristics of dengue virus and potential targets for drug design.
    Qi RF; Zhang L; Chi CW
    Acta Biochim Biophys Sin (Shanghai); 2008 Feb; 40(2):91-101. PubMed ID: 18235970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The medicinal chemistry of dengue fever.
    Stevens AJ; Gahan ME; Mahalingam S; Keller PA
    J Med Chem; 2009 Dec; 52(24):7911-26. PubMed ID: 19739651
    [No Abstract]   [Full Text] [Related]  

  • 4. Strategies for the treatment of dengue virus infections: a narrative account.
    De Clercq E
    Future Med Chem; 2010 Apr; 2(4):601-8. PubMed ID: 21426010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Towards antiviral therapies for treating dengue virus infections.
    Kaptein SJ; Neyts J
    Curr Opin Pharmacol; 2016 Oct; 30():1-7. PubMed ID: 27367615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Important advances in the field of anti-dengue virus research.
    Julander JG; Perry ST; Shresta S
    Antivir Chem Chemother; 2011; 21(3):105-16. PubMed ID: 21233532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent advances in antiviral drug development towards dengue virus.
    Troost B; Smit JM
    Curr Opin Virol; 2020 Aug; 43():9-21. PubMed ID: 32795907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel strategies for discovering inhibitors of Dengue and Zika fever.
    Makhluf H; Kim K; Shresta S
    Expert Opin Drug Discov; 2016 Oct; 11(10):921-3. PubMed ID: 27401601
    [No Abstract]   [Full Text] [Related]  

  • 9. Targeting a host process as an antiviral approach against dengue virus.
    Sayce AC; Miller JL; Zitzmann N
    Trends Microbiol; 2010 Jul; 18(7):323-30. PubMed ID: 20452219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Antiviral strategies. Dengue and West Nile Virus].
    Klein C
    Pharm Unserer Zeit; 2010; 39(1):50-3. PubMed ID: 20033943
    [No Abstract]   [Full Text] [Related]  

  • 11. Dengue viral infection.
    Sarin YK; Singh S; Singh T
    Indian Pediatr; 1998 Feb; 35(2):129-37. PubMed ID: 9707855
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dengue Antiviral Development: A Continuing Journey.
    Low JG; Gatsinga R; Vasudevan SG; Sampath A
    Adv Exp Med Biol; 2018; 1062():319-332. PubMed ID: 29845542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunological enhancement of dengue virus replication.
    Halstead SB; Chow JS; Marchette NJ
    Nat New Biol; 1973 May; 243(122):24-6. PubMed ID: 17319077
    [No Abstract]   [Full Text] [Related]  

  • 14. Dengue vaccines: state of the art.
    Swaminathan S; Batra G; Khanna N
    Expert Opin Ther Pat; 2010 Jun; 20(6):819-35. PubMed ID: 20384534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An Industry Perspective on Dengue Drug Discovery and Development.
    Hernandez-Morales I; Van Loock M
    Adv Exp Med Biol; 2018; 1062():333-353. PubMed ID: 29845543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progress for dengue virus diseases. Towards the NS2B-NS3pro inhibition for a therapeutic-based approach.
    Melino S; Paci M
    FEBS J; 2007 Jun; 274(12):2986-3002. PubMed ID: 17509079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drugs for dengue: a patent review (2010-2014).
    Beesetti H; Khanna N; Swaminathan S
    Expert Opin Ther Pat; 2014 Nov; 24(11):1171-84. PubMed ID: 25283170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Towards the design of antiviral inhibitors against flaviviruses: the case for the multifunctional NS3 protein from Dengue virus as a target.
    Lescar J; Luo D; Xu T; Sampath A; Lim SP; Canard B; Vasudevan SG
    Antiviral Res; 2008 Nov; 80(2):94-101. PubMed ID: 18674567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dengue fever: diagnosis and treatment.
    Wiwanitkit V
    Expert Rev Anti Infect Ther; 2010 Jul; 8(7):841-5. PubMed ID: 20586568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiviral activity of carbohydrate-binding agents and the role of DC-SIGN in dengue virus infection.
    Alen MM; Kaptein SJ; De Burghgraeve T; Balzarini J; Neyts J; Schols D
    Virology; 2009 Apr; 387(1):67-75. PubMed ID: 19264337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.